January 27, 2016
Dasatinib Action Letter: GOG-0283 and RTOG 0627

CTEP has issued an Action letter for Dasatinib along with an updated CAEPR and Risk List for distribution to all investigators using this agent. The following protocols are affected by this action letter:

GOG-0283 Amendment #4: For details, please see the GOG Weekly Mailing page.

RTOG 0627 Amendment #12: For details, please see the RTOG 0627 protocol-specific web page.

View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.

Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103